Brian McCormick
Family · Seneca, SCNPI 1861584419
Payments from drug & device makers
Across 120 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$643
- Lilly USA, LLC$274
- AstraZeneca$181
- Exact Sciences$115
- Edwards Lifesciences$76
- Pfizer$67
- plus $428 from 13 others
What the payments were for
- Food & beverage$1,784100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $643 |
| Lilly USA, LLC | 20 | $274 |
| AstraZeneca | 10 | $181 |
| Exact Sciences | 8 | $115 |
| Edwards Lifesciences | 2 | $76 |
| Pfizer | 4 | $67 |
| Abbott | 3 | $65 |
| GSK | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Amgen | 2 | $39 |
| Novartis | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Merck | 1 | $16 |
How this compares
$1,784 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $75,817 |
| XareltoRivaroxaban | 19 | $14,783 |
| JardianceEmpagliflozin | 14 | $14,568 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $14,352 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,735 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $3,345 |
| Rosuvastatin Calcium | 104 | $1,250 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $1,054 |
| Levothyroxine Sodium | 99 | $1,011 |
| Atorvastatin Calcium | 73 | $879 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 15 | $737 |
| Potassium Chloride | 26 | $705 |
| Gabapentin | 44 | $680 |
| Losartan Potassium | 79 | $639 |
| Duloxetine Hcl | 21 | $519 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $643 | $75,81757 claims |
| Johnson & JohnsonXarelto | $19 | $14,78319 claims |
| GSKTrelegy Ellipta | $54 | $14,35219 claims |
| AstraZenecaBreztri Aerosphere | $181 | $6,73511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,248 family providers in South Carolina.
Other family in Seneca
- Kristine BoswellSeneca$17K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.